Drug Companies Share Data To Speed Brain Research

A dozen competing drug companies are coming together in hopes of finding new treatments for Alzheimer's.In an unusual step, the drug companies have agreed to share data on more than 4,000 Alzheimer's patients. By pooling resources from clinical trials, scientists can hunt trends that may suggest what to study next.The database was created in consultation with government regulators and the National Institutes of Health. It'll also be available to brain researchers not affiliated with drug companies in hopes of eventually addressing other brain diseases such as Parkinson's.To respond to News 8 This Morning's Question of the Day, please write your response in the u local box at the bottom of this page. Your response could be read during News 8 This Morning between 5 a.m. and 7 a.m.